Nancy Andrews is a board member at Maze Therapeutics and a previous executive at Charles River Laboratories. Nancy also has experience as a member of the executive committee of the corporation at the Massachusetts Institute of Technology, Dyne Therapeutics, American Academy of Arts & Sciences, Novartis, and Duke University. Nancy also was the Dean for Basic Sciences and Graduate Studies at Harvard Medical School and an attending physician at Boston Children's Hospital where they were also a faculty researcher until 2008.
Dr. Nancy Andrews is a Fellow of Pediatric Hematology-Oncology at Boston Children's Hospital and Dana-Farber Cancer Institute. Nancy is also a Resident of Pediatrics at Boston Children's Hospital. Dr. Andrews received their Doctor of Medicine (MD) from Harvard Medical School and their Doctor of Philosophy (PhD) in Biology from the Massachusetts Institute of Technology. Nancy also holds a BS and MS in Molecular Biophysics and Biochemistry from Yale University.